Key result
HCV is linked to ~22% anticardiolipin antibody positivity.
Why the study?
Is hepatitis C virus associated with the presence of anticardiolipin antibodies and antiphospholipid syndrome?
Observational (n=225)
Is hepatitis C virus associated with the presence of anticardiolipin antibodies and antiphospholipid syndrome?
Answers are grounded in this paper and cite their sources.
The study investigates the potential role of Hepatitis C virus as a cause of antiphospholipid syndrome by evaluating antibody prevalence in HCV and thrombotic disorder cohorts.
¡Antiphospholipid antibodies are a type of autoantibodies that have been implicated in the occurrence of thrombocytopenia and thrombotic events and have been described in autoimmune disorders and diverse viral diseases.In this study anticard iolipin antibodies (immunoglobulin G [l gG] isotype) were determined in serum from 1 00 patients w ith chronic hepatitis e and 52 healthy controls.In addition, hepatitis e virus (H e V) markerts (anti-H eV and ev RNA) were investi gated in 73 patients w ith thrombotic disorders and no c linical evidence of liver disease ; of th ese patients 37 cases tested negati vely for anticard iolipin antibodies and 36 positively.Anticardiolipin test was positive more frequently (22 %) in the group of patients with
No takes yet. Share an insight, caveat, or question.
Prìeto et al. (2017) conducted an observational in Chronic hepatitis C and thrombotic disorders (n=225). Hepatitis C Virus infection vs. Healthy controls was evaluated on Anticardiolipin antibody positivity. Anticardiolipin antibodies were positive in 22% of a patient group, investigating the role of hepatitis C virus in antiphospholipid syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: